BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10030268)

  • 1. p53 function influences the effect of fractionated radiotherapy on glioblastoma tumors.
    Haas-Kogan DA; Kogan SS; Yount G; Hsu J; Haas M; Deen DF; Israel MA
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):399-403. PubMed ID: 10030268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53-dependent G1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma.
    Haas-Kogan DA; Yount G; Haas M; Levi D; Kogan SS; Hu L; Vidair C; Deen DF; Dewey WC; Israel MA
    Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):95-103. PubMed ID: 8823264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53-independent apoptosis: a mechanism of radiation-induced cell death of glioblastoma cells.
    Haas-Kogan DA; Dazin P; Hu L; Deen DF; Israel A
    Cancer J Sci Am; 1996; 2(2):114-21. PubMed ID: 9166509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines.
    Rubner Y; Muth C; Strnad A; Derer A; Sieber R; Buslei R; Frey B; Fietkau R; Gaipl US
    Radiat Oncol; 2014 Mar; 9(1):89. PubMed ID: 24678590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
    Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
    J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An accelerated senescence response to radiation in wild-type p53 glioblastoma multiforme cells.
    Quick QA; Gewirtz DA
    J Neurosurg; 2006 Jul; 105(1):111-8. PubMed ID: 16871885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Functional restoration of tumor suppressor p53 alters susceptibility of glioblastoma cells to irradiation--analysis using a cell line containing a temperature-sensitive mutant].
    Tsuchiya K
    Hokkaido Igaku Zasshi; 2000 Jul; 75(4):265-74. PubMed ID: 10976406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation of TRADD mediates p53-independent radiation-induced apoptosis of glioma cells.
    Yount GL; Afshar G; Ries S; Korn M; Shalev N; Basila D; McCormick F; Haas-Kogan DA
    Oncogene; 2001 May; 20(22):2826-35. PubMed ID: 11420694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A spatio-temporal simulation model of the response of solid tumours to radiotherapy in vivo: parametric validation concerning oxygen enhancement ratio and cell cycle duration.
    Antipas VP; Stamatakos GS; Uzunoglu NK; Dionysiou DD; Dale RG
    Phys Med Biol; 2004 Apr; 49(8):1485-504. PubMed ID: 15152687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-dependent radiosensitivity: clonogenic survival, apoptosis and cell-cycle redistribution.
    Williams JR; Zhang Y; Zhou H; Russell J; Gridley DS; Koch CJ; Little JB
    Int J Radiat Biol; 2008 Feb; 84(2):151-64. PubMed ID: 18246483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential radiosensitizing potential of temozolomide in MGMT promoter methylated glioblastoma multiforme cell lines.
    van Nifterik KA; van den Berg J; Stalpers LJ; Lafleur MV; Leenstra S; Slotman BJ; Hulsebos TJ; Sminia P
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1246-53. PubMed ID: 17967314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
    Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells.
    Yount GL; Haas-Kogan DA; Vidair CA; Haas M; Dewey WC; Israel MA
    Cancer Res; 1996 Feb; 56(3):500-6. PubMed ID: 8564961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction.
    Broaddus WC; Liu Y; Steele LL; Gillies GT; Lin PS; Loudon WG; Valerie K; Schmidt-Ullrich RK; Fillmore HL
    J Neurosurg; 1999 Dec; 91(6):997-1004. PubMed ID: 10584846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic damage and the radiation-induced G1-phase checkpoint.
    Gupta N; Vij R; Haas-Kogan DA; Israel MA; Deen DF; Morgan WF
    Radiat Res; 1996 Mar; 145(3):289-98. PubMed ID: 8927696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cells co-cultured with wild-type and dominant/negative p53-transfected glioblastoma cells exhibit differential sensitivity to radiation-induced apoptosis.
    Khodarev NN; Labay E; Darga T; Yu J; Mauceri H; Gupta N; Kataoka Y; Weichselbaum RR
    Int J Cancer; 2004 Mar; 109(2):214-9. PubMed ID: 14750172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR overexpression and radiation response in glioblastoma multiforme.
    Barker FG; Simmons ML; Chang SM; Prados MD; Larson DA; Sneed PK; Wara WM; Berger MS; Chen P; Israel MA; Aldape KD
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):410-8. PubMed ID: 11567815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of radiation-induced G2 delay potentiates cell death by apoptosis and/or the induction of giant cells in colorectal tumor cells with disrupted p53 function.
    Bracey TS; Williams AC; Paraskeva C
    Clin Cancer Res; 1997 Aug; 3(8):1371-81. PubMed ID: 9815821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined radiation and p53 gene therapy of malignant glioma cells.
    Badie B; Goh CS; Klaver J; Herweijer H; Boothman DA
    Cancer Gene Ther; 1999; 6(2):155-62. PubMed ID: 10195882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p53 and p21 in primary glioblastomas.
    Gross MW; Kraus A; Nashwan K; Mennel HD; Engenhart-Cabillic R; Schlegel J
    Strahlenther Onkol; 2005 Mar; 181(3):164-71. PubMed ID: 15756520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.